Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Pulmonary Hypertension, May 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 92 articles:
HTML format


 

Single Articles

  1. IBE T, Wada H, Sakakura K, Yoshimura S, et al
    Residual pulmonary hypertension is associated with clinical outcomes in patients with acute pulmonary thromboembolism.
    Heart Vessels. 2019 May 2. pii: 10.1007/s00380-019-01420.
    Abstract    

    Abstract available

  2. DE-MIGUEL-DIEZ J, Lopez-de-Andres A, Hernandez-Barrera V, Jimenez-Trujillo I, et al
    Retrospective observational analysis of hospital discharge database to characterize primary pulmonary hypertension and its outcomes in Spain from 2004 to 2015.
    Medicine (Baltimore). 2019;98:e15518.
    Abstract    

    Abstract available

  3. EL YAFAWI R, Rancourt D, Hacobian M, Atherton D, et al
    EXPRESS: Pulmonary Hypertension Subjects Exhibit Right Ventricular Transient Exertional Dilation during Supine Exercise Stress Echocardiography.
    Pulm Circ. 2019 May 2:2045894019851904. doi: 10.1177/2045894019851904.
    Abstract    



  4. ZHANG Y, Yu X, Jin Q, Luo Q, et al
    Advances in targeted therapy for chronic thromboembolic pulmonary hypertension.
    Heart Fail Rev. 2019 May 1. pii: 10.1007/s10741-019-09798.
    Abstract    

    Abstract available

  5. LIU BY, Wu WC, Zeng QX, Liu ZH, et al
    Two-dimensional speckle tracking echocardiography assessed right ventricular function and exercise capacity in pre-capillary pulmonary hypertension.
    Int J Cardiovasc Imaging. 2019 Apr 29. pii: 10.1007/s10554-019-01605.
    Abstract    

    Abstract available

  6. MERABET N, Nsaibia MJ, Nguyen QT, Shi YF, et al
    PulmoBind Imaging Measures Reduction of Vascular Adrenomedullin Receptor Activity with Lack of effect of Sildenafil in Pulmonary Hypertension.
    Sci Rep. 2019;9:6609.
    Abstract    

    Abstract available

  7. COLLUM SD, Molina JG, Hanmandlu A, Bi W, et al
    Adenosine and hyaluronan modulate lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema (CPFE).
    Dis Model Mech. 2019 Apr 29. pii: dmm.038711. doi: 10.1242/dmm.038711.
    Abstract    

    Abstract available

  8. SINGHAL R
    Unilateral interruption of pulmonary artery with pulmonary hypertension: a case for heart lung transplantation?
    Cardiol Young. 2019 Apr 30:1-4. doi: 10.1017/S1047951119000271.
    Abstract    

    Abstract available

  9. FU J, Bai P, Chen Y, Yu T, et al
    Inhibition of miR-495 Improves Both Vascular Remodeling and Angiogenesis in Pulmonary Hypertension.
    J Vasc Res. 2019 Apr 26:1-10. doi: 10.1159/000500024.
    Abstract    

    Abstract available

  10. KOHNO T, Fukuoka R, Kawakami T, Kataoka M, et al
    Balloon pulmonary angioplasty attenuates sleep apnea in patients with chronic thromboembolic pulmonary hypertension.
    Heart Lung. 2019 Apr 24. pii: S0147-9563(18)30521.
    Abstract    

    Abstract available

  11. YANG Y, Du H, Li Y, Guan W, et al
    NR3C1 gene polymorphisms are associated with high-altitude pulmonary edema in Han Chinese.
    J Physiol Anthropol. 2019;38:4.
    Abstract    

    Abstract available

  12. MUSANI AI
    Pulmonary Disease.
    Med Clin North Am. 2019;103:xix-xx.
    Abstract    



  13. KOESTENBERGER M, Sallmon H, Hansmann G
    A pediatric perspective on the TAPSE/PASP ratio in pulmonary arterial hypertension.
    Int J Cardiol. 2019;278:242.
    Abstract    



  14. TELLO K, Naeije R, Ghofrani HA, Gall H, et al
    Reply to "a pediatric perspective on the TAPSE/PASP ratio in pulmonary arterial hypertension".
    Int J Cardiol. 2019;278:240-241.
    Abstract    



  15. SCHUBA B, Michel S, Guenther S, Weig T, et al
    Lung transplantation in patients with severe pulmonary hypertension - Focus on right ventricular remodeling.
    Clin Transplant. 2019 May 10:e13586. doi: 10.1111/ctr.13586.
    Abstract    

    Abstract available

  16. LARISSI K, Politou M, Margeli A, Poziopoulos C, et al
    The Growth Differentiation Factor-15 (GDF-15) levels are increased in patients with compound heterozygous sickle cell and beta-thalassemia (HbS/beta(thal)), correlate with markers of hemolysis, iron burden, coagulation, endothelial dysfunction and pul
    Blood Cells Mol Dis. 2019;77:137-141.
    Abstract    

    Abstract available

  17. APATEAN D, Rakic B, Brunel-Guitton C, Hendson G, et al
    Congenital lactic acidosis, cerebral cysts and pulmonary hypertension in an infant with FOXRED1 related complex 1 deficiency.
    Mol Genet Metab Rep. 2019;19:100472.
    Abstract    

    Abstract available

  18. SUTO M, Matsumoto K, Kido S, Mori S, et al
    Advanced Pulmonary Hypertension Due to Congenital Double-shunt Successfully Treated with Surgical Repair and Up-front Combination Therapy.
    Intern Med. 2019;58:1301-1305.
    Abstract    

    Abstract available

  19. INAMI T, Kataoka M, Kikuchi H, Goda A, et al
    Balloon pulmonary angioplasty for symptomatic chronic thromboembolic disease without pulmonary hypertension at rest.
    Int J Cardiol. 2019 Apr 30. pii: S0167-5273(19)30710.
    Abstract    

    Abstract available

  20. SUN Z, Liu Y, Yu F, Xu Y, et al
    Long non-coding RNA and mRNA profile analysis of metformin to reverse the pulmonary hypertension vascular remodeling induced by monocrotaline.
    Biomed Pharmacother. 2019;115:108933.
    Abstract    

    Abstract available

  21. ZHANG J, Li JM, Huang ZS, Xu JC, et al
    A meta-analysis of randomized controlled trials in targeted treatments of chronic thromboembolic pulmonary hypertension.
    Clin Respir J. 2019 May 6. doi: 10.1111/crj.13034.
    Abstract    

    Abstract available

  22. BERTERO T, Perk D, Chan SY
    The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension.
    Expert Opin Ther Targets. 2019 May 4. doi: 10.1080/14728222.2019.1615438.
    Abstract    

    Abstract available

  23. UEDA Y, Johnson LR, Ontiveros ES, Visser LC, et al
    Effect of a phosphodiesterase-5A (PDE5A) gene polymorphism on response to sildenafil therapy in canine pulmonary hypertension.
    Sci Rep. 2019;9:6899.
    Abstract    

    Abstract available

  24. MILES JA, Wan N, Murthy S
    Massive Pulmonary Artery Dilatation in a Case of Chronic Thromboembolic Pulmonary Hypertension.
    Am J Med. 2019 Apr 30. pii: S0002-9343(19)30346.
    Abstract    



  25. XIA XD, Peng YP, Lei D, Chen WQ, et al
    Hypercapnia downregulates hypoxia-induced lysyl oxidase expression in pulmonary artery smooth muscle cells via inhibiting transforming growth factor beta1 signalling.
    Cell Biochem Funct. 2019;37:193-202.
    Abstract    

    Abstract available

  26. ALBAYRAK M, Atila A, Yilmazel Ucar E, Araz O, et al
    A novel, rapid and sensitive UPLC-MS/MS method for the determination of macitentan in patients with pulmonary arterial hypertension.
    Biomed Chromatogr. 2019;33:e4502.
    Abstract    

    Abstract available

  27. JIN T, Zhu L, Bai M, He X, et al
    Association between the IL1R2 rs2072472 polymorphism and high-altitude pulmonary edema risk.
    Mol Genet Genomic Med. 2019;7:e542.
    Abstract    

    Abstract available

  28. MORTIMER K, Hartmann N, Chan C, Norman H, et al
    Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data.
    BMC Pulm Med. 2019;19:11.
    Abstract    

    Abstract available

  29. MARASCO G, Colecchia A, Dajti E, Ravaioli F, et al
    Prediction of posthepatectomy liver failure: Role of SSM and LSPS.
    J Surg Oncol. 2019;119:400-401.
    Abstract    



  30. WANG SC, Garcia R, Torosoff M, Fein SA, et al
    Influence of mildly and moderately elevated pulmonary artery systolic pressure on post-renal transplantation survival and graft function.
    Echocardiography. 2019;36:22-27.
    Abstract    

    Abstract available

  31. SCHOENFELD C, Hinrichs JB, Olsson KM, Kuettner MA, et al
    Cardio-pulmonary MRI for detection of treatment response after a single BPA treatment session in CTEPH patients.
    Eur Radiol. 2019;29:1693-1702.
    Abstract    

    Abstract available

  32. SOHN B, Park S, Park IK, Kim YT, et al
    Lung Volume Reduction Surgery for Respiratory Failure in Infants With Bronchopulmonary Dysplasia.
    Pediatrics. 2018;141.
    Abstract    

    Abstract available

  33. ELLIOTT CG, Austin E, Badesch D, Badlam J, et al
    EXPRESS: United States Pulmonary Hypertension Scientific Registry (USPHSR): Rationale, design, and clinical implications.
    Pulm Circ. 2019 May 17:2045894019851696. doi: 10.1177/2045894019851696.
    Abstract    



  34. KOESTENBERGER M, Sallmon H, Avian A, Cantinotti M, et al
    EXPRESS: Ventricular-ventricular interaction variables correlate with surrogate variables of clinical outcome in children with pulmonary hypertension.
    Pulm Circ. 2019 May 17:2045894019854074. doi: 10.1177/2045894019854074.
    Abstract    



  35. SUDA R, Tanabe N, Terada J, Naito A, et al
    Pulmonary hypertension with a low cardiac index requires a higher PaO2 level to avoid tissue hypoxia.
    Respirology. 2019 May 16. doi: 10.1111/resp.13574.
    Abstract    

    Abstract available

  36. CARVALHO CG, Yadollahi A, Granton J, Ryan CM, et al
    Temporal shifts in fluid in pulmonary hypertension with and without sleep apnea.
    J Sleep Res. 2019 May 16:e12863. doi: 10.1111/jsr.12863.
    Abstract    

    Abstract available

  37. DEL REY HURTADO DE MENDOZA B, Sanchez-de-Toledo J, Bobillo Perez S, Girona M, et al
    Lung Ultrasound to Assess the Etiology of Persistent Pulmonary Hypertension of the Newborn (LUPPHYN Study): A Pilot Study.
    Neonatology. 2019 May 16:1-7. doi: 10.1159/000499047.
    Abstract    

    Abstract available

  38. AVITABILE CM, Ansems S, Wang Y, Fraga MV, et al
    Accuracy of Brain Natriuretic Peptide for Diagnosing Pulmonary Hypertension in Severe Bronchopulmonary Dysplasia.
    Neonatology. 2019 May 16:1-7. doi: 10.1159/000499082.
    Abstract    

    Abstract available

  39. ANDERLUH M, Kocic G, Tomovic K, Kocic H, et al
    DPP-4 inhibition: capital A, Cyrillic novel therapeutic approach to the treatment of pulmonary hypertension?
    Pharmacol Ther. 2019 May 13. pii: S0163-7258(19)30081.
    Abstract    

    Abstract available

  40. LEI S, Sun Z, He X, Li C, et al
    Clinical characteristics of pulmonary hypertension patients living in plain and high-altitude regions.
    Clin Respir J. 2019 May 16. doi: 10.1111/crj.13049.
    Abstract    

    Abstract available

  41. DANILOV NM, Matchin YG, Chernyavsky AM, Edemsky AG, et al
    Balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension.
    Ter Arkh. 2019;91:43-47.
    Abstract    

    Abstract available

  42. SAKHNOVA TA, Blinova EV, Belevskaya AA, Saidova MA, et al
    Comparison of the integral indices of the vectorcardiogram with the data of echocardiography in patients with idiopathic and chronic thromboembolic pulmonary hypertension.
    Ter Arkh. 2019;91:11-16.
    Abstract    

    Abstract available

  43. BESEN BAMP, Romano TG, Zigaib R, Mendes PV, et al
    Oxygen delivery, carbon dioxide removal, energy transfer to lungs and pulmonary hypertension behavior during venous-venous extracorporeal membrane oxygenation support: a mathematical modeling approach.
    Rev Bras Ter Intensiva. 2019 May 13. pii: S0103-507X2019005006102.
    Abstract    

    Abstract available

  44. PETER ID, Asani MO, Abdullahi SU, Aliyu I, et al
    Pulmonary hypertension and right ventricular function in Nigerian children with sickle cell anaemia.
    Trans R Soc Trop Med Hyg. 2019 May 14. pii: 5489111. doi: 10.1093.
    Abstract    

    Abstract available

  45. DABRAL S, Muecke C, Valasarajan C, Schmoranzer M, et al
    A RASSF1A-HIF1alpha loop drives Warburg effect in cancer and pulmonary hypertension.
    Nat Commun. 2019;10:2130.
    Abstract    

    Abstract available

  46. LIU Y, Xu Y, Zhu J, Li H, et al
    Metformin Prevents Progression of Experimental Pulmonary Hypertension via Inhibition of Autophagy and Activation of Adenosine Monophosphate-Activated Protein Kinase.
    J Vasc Res. 2019 May 14:1-12. doi: 10.1159/000498894.
    Abstract    

    Abstract available

  47. XING XQ, Li B, Xu SL, Zhang CF, et al
    5-Aza-2'-deoxycytidine, a DNA methylation inhibitor, attenuates hypoxic pulmonary hypertension via demethylation of the PTEN promoter.
    Eur J Pharmacol. 2019 May 11. pii: S0014-2999(19)30325.
    Abstract    

    Abstract available

  48. HOTZEL A, Loop T
    [Anaesthesia in Patients with Pulmonary Hypertension].
    Anasthesiol Intensivmed Notfallmed Schmerzther. 2019;54:334-346.
    Abstract    

    Abstract available

  49. LUCKE E, Schmeisser A, Schreiber J
    [Pulmonary Hypertension: Diagnostics, Classification and Therapy].
    Anasthesiol Intensivmed Notfallmed Schmerzther. 2019;54:320-333.
    Abstract    

    Abstract available

  50. SOMANI A, Nair SL, Milbauer LC, Zhu G, et al
    Blood outgrowth endothelial cells overexpressing eNOS mitigate pulmonary hypertension in rats: a unique carrier cell enabling autologous cell-based gene therapy.
    Transl Res. 2019 Apr 24. pii: S1931-5244(19)30079.
    Abstract    

    Abstract available

  51. ZHAO TF, Wang SY, Zou XZ, Zhao HD, et al
    MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1.
    Eur Rev Med Pharmacol Sci. 2019;23:3495-3502.
    Abstract    

    Abstract available

  52. VALLERAND JR, Weatherald J, Laveneziana P
    Pulmonary Hypertension and Exercise.
    Clin Chest Med. 2019;40:459-469.
    Abstract    

    Abstract available

  53. IWAYA Y, Muneuchi J, Inoue Y, Watanabe M, et al
    Relationship Between Pulmonary Arterial Resistance and Compliance in Patients with Down Syndrome.
    Pediatr Cardiol. 2019;40:841-847.
    Abstract    

    Abstract available

  54. ZUK M, Migdal A, Dominczak J, Brzezinska-Rajszys G, et al
    Usefulness of Red Cell Width Distribution (RDW) in the Assessment of Children with Pulmonary Arterial Hypertension (PAH).
    Pediatr Cardiol. 2019;40:820-826.
    Abstract    

    Abstract available

  55. PHILIP R, Nathaniel Johnson J, Naik R, Kimura D, et al
    Effect of patent ductus arteriosus on pulmonary vascular disease.
    Congenit Heart Dis. 2019;14:37-41.
    Abstract    

    Abstract available

  56. KULIK TJ, McSweeney JE, Tella J, Mullen MP, et al
    Pulmonary Artery Banding in Post-tricuspid Congenital Cardiac Shunting Defects with High Pulmonary Vascular Resistance.
    Pediatr Cardiol. 2019;40:719-725.
    Abstract    

    Abstract available

  57. BERTELOOT L, Proisy M, Jais JP, Levy M, et al
    Idiopathic, heritable and veno-occlusive pulmonary arterial hypertension in childhood: computed tomography angiography features in the initial assessment of the disease.
    Pediatr Radiol. 2019 Jan 16. pii: 10.1007/s00247-018-04331.
    Abstract    

    Abstract available

  58. SHIBATA A, Uchida K, Kodo K, Miyauchi T, et al
    Type 2 inositol 1,4,5-trisphosphate receptor inhibits the progression of pulmonary arterial hypertension via calcium signaling and apoptosis.
    Heart Vessels. 2019;34:724-734.
    Abstract    

    Abstract available

  59. CLAVE MM, Maeda NY, Thomaz AM, Bydlowski SP, et al
    Phosphodiesterase type 5 inhibitors improve microvascular dysfunction markers in pulmonary arterial hypertension associated with congenital heart disease.
    Congenit Heart Dis. 2019;14:246-255.
    Abstract    

    Abstract available

  60. KAZIMIERCZYK R, Blaszczak P, Jasiewicz M, Knapp M, et al
    Increased platelet content of SDF-1alpha is associated with worse prognosis in patients with pulmonary prterial hypertension.
    Platelets. 2019;30:445-451.
    Abstract    

    Abstract available

  61. KIPFMUELLER F, Schroeder L, Berg C, Heindel K, et al
    Continuous intravenous sildenafil as an early treatment in neonates with congenital diaphragmatic hernia.
    Pediatr Pulmonol. 2018 Jan 5. doi: 10.1002/ppul.23935.
    Abstract    

    Abstract available

  62. BORLAUG BA, Obokata M
    Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease.
    Eur Heart J. 2017 Apr 17. doi: 10.1093.
    Abstract    



  63. YOUNG JM, Williams DR, Thompson AAR
    Thin Air, Thick Vessels: Historical and Current Perspectives on Hypoxic Pulmonary Hypertension.
    Front Med (Lausanne). 2019;6:93.
    Abstract    

    Abstract available

  64. DING F, You T, Hou XD, Yi K, et al
    MiR-21 regulates pulmonary hypertension in rats via TGF-beta1/Smad2 signaling pathway.
    Eur Rev Med Pharmacol Sci. 2019;23:3984-3992.
    Abstract    

    Abstract available

  65. MARGELIDON-COZZOLINO V, Delavenne X, Catella-Chatron J, De Magalhaes E, et al
    Indications and potential pitfalls of anticoagulants in pulmonary hypertension: Would DOACs become a better option than VKAs?
    Blood Rev. 2019 May 15. pii: S0268-960X(19)30019.
    Abstract    

    Abstract available

  66. CORDINA RL, Playford D, Lang I, Celermajer DS, et al
    State-of-the-Art Review: Echocardiography in Pulmonary Hypertension.
    Heart Lung Circ. 2019 Apr 30. pii: S1443-9506(19)30291.
    Abstract    

    Abstract available

  67. ZOLTY R
    Challenges in pulmonary hypertension associated with left heart disease.
    Expert Rev Cardiovasc Ther. 2019 May 20. doi: 10.1080/14779072.2019.1615885.
    Abstract    

    Abstract available

  68. DOYLE-COX C, Nicholson G, Stewart T, Gin-Sing W, et al
    EXPRESS: Current organization of specialist pulmonary hypertension clinics: results of an international survey.
    Pulm Circ. 2019 May 20:2045894019855611. doi: 10.1177/2045894019855611.
    Abstract    



  69. JAYASEKERA G, Johnson M, Hussey K, Church C, et al
    Pulmonary hypertension and severe right heart failure following lumbar spinal surgery.
    SAGE Open Med Case Rep. 2019;7:2050313X19847805.
    Abstract    

    Abstract available

  70. KIMURA D, McNamara IF, Wang J, Fowke JH, et al
    Pulmonary hypertension during respiratory syncytial virus bronchiolitis: a risk factor for severity of illness.
    Cardiol Young. 2019 May 20:1-5. doi: 10.1017/S1047951119000313.
    Abstract    

    Abstract available

  71. KATAOKA M, Inami T, Kawakami T, Fukuda K, et al
    Balloon Pulmonary Angioplasty (Percutaneous Transluminal Pulmonary Angioplasty) for Chronic Thromboembolic Pulmonary Hypertension: A Japanese Perspective.
    JACC Cardiovasc Interv. 2019 May 11. pii: S1936-8798(19)30402.
    Abstract    

    Abstract available

  72. KIGITOVICA D, Sablinskis M, Sablinskis K, Rudzitis A, et al
    Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension incidence in Latvia in 2018.
    Eur J Intern Med. 2019 May 14. pii: S0953-6205(19)30142.
    Abstract    



  73. AKGUL F, Batyraliev TA, Fettser DV, Seyfeli E, et al
    [Decreased Heart Rate Variability in Sickle Cell Anemia as Effect of Pulmonary Arterial Hypertension].
    Kardiologiia. 2019;59:39-44.
    Abstract    

    Abstract available

  74. VAN DISSEL AC, Blok IM, Zwinderman AH, van Dijk APJ, et al
    Prognostic value of multiple repeated biomarkers in pulmonary arterial hypertension associated with congenital heart disease.
    Eur J Heart Fail. 2019;21:249-251.
    Abstract    



  75. THENAPPAN T, Weir EK
    The Nitric Oxide Pathway-A Potential Target for Precision Medicine in Pulmonary Arterial Hypertension.
    Am J Cardiol. 2017;120.
    Abstract    



  76. SIMON MA, Maron BA
    Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction Patients: Where to Draw the Line.
    Am J Respir Crit Care Med. 2019 Apr 30. doi: 10.1164/rccm.201903-0689.
    Abstract    



  77. KOJONAZAROV B, Hadzic S, Ghofrani HA, Grimminger F, et al
    Severe Emphysema in the SU5416/Hypoxia Rat Model of Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2019 Apr 29. doi: 10.1164/rccm.201902-0390.
    Abstract    



  78. SAKURAI Y, Takami Y, Amano K, Higuchi Y, et al
    Predictors of Outcomes after Surgery for Chronic Thromboembolic Pulmonary Hypertension.
    Ann Thorac Surg. 2019 May 7. pii: S0003-4975(19)30622.
    Abstract    

    Abstract available

  79. SINGH I, Oliveira RKF, Naeije R, Rahaghi FN, et al
    Pulmonary Vascular Distensibility and Early Pulmonary Vascular Remodeling in Pulmonary Hypertension.
    Chest. 2019 May 20. pii: S0012-3692(19)31063-3. doi: 10.1016/j.chest.2019.
    Abstract    

    Abstract available

  80. ZELT JGE, Chaudhary KR, Cadete VJ, Mielniczuk LM, et al
    Medical Therapy for Heart Failure Associated With Pulmonary Hypertension.
    Circ Res. 2019;124:1551-1567.
    Abstract    

    Abstract available

  81. KIM B, Arany Z
    Does Glycine cataBOLAsm Drive Pulmonary Hypertension?
    Circulation. 2019;139:2256-2259.
    Abstract    



  82. DA SILVA GONCALVES BOS D, Van Der Bruggen CE, Kurakula K, Sun XQ, et al
    Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    Circulation. 2017 Nov 22. pii: CIRCULATIONAHA.117.027451.
    Abstract    

    Abstract available

  83. ULRICH S, Saxer S, Hasler ED, Schwarz EI, et al
    Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial.
    Eur Respir J. 2019 May 9. pii: 13993003.002762019.
    Abstract    

    Abstract available

  84. TELLO K, Ghofrani HA, Heinze C, Krueger K, et al
    A simple echocardiographic estimate of right ventricular-arterial coupling to assess severity and outcome in pulmonary hypertension on chronic lung disease.
    Eur Respir J. 2019 May 9. pii: 13993003.02435-2018.
    Abstract    



  85. VAN DE BRUAENE A, Toh N, Hickey EJ, Benson L, et al
    Pulmonary hypertension in patients with a subaortic right ventricle: prevalence, impact and management.
    Heart. 2019 May 3. pii: heartjnl-2019-314756. doi: 10.1136/heartjnl-2019-314756.
    Abstract    

    Abstract available

  86. OKAMOTO C, Okada A, Kanzaki H, Nishimura K, et al
    Prognostic impact of peak mitral inflow velocity in asymptomatic degenerative mitral regurgitation.
    Heart. 2018 Oct 20. pii: heartjnl-2018-313733. doi: 10.1136/heartjnl-2018-313733
    Abstract    

    Abstract available

  87. KEMPNY A, Dimopoulos K, Fraisse A, Diller GP, et al
    Blood Viscosity and its Relevance to the Diagnosis and Management of Pulmonary Hypertension.
    J Am Coll Cardiol. 2019;73:2640-2642.
    Abstract    



  88. ALFONSO F, Rivero F
    Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension.
    J Am Coll Cardiol. 2017;69:2818-2820.
    Abstract    



  89. TANIGUCHI Y, Jais X, Jevnikar M, Boucly A, et al
    Predictors of survival in patients with not-operated chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2019 Apr 27. pii: S1053-2498(19)31474.
    Abstract    

    Abstract available

  90. CHAUSHEVA S, Naito A, Ogawa A, Seidl V, et al
    Chronic thromboembolic pulmonary hypertension in Austria and Japan.
    J Thorac Cardiovasc Surg. 2019 Jan 21. pii: S0022-5223(19)30071.
    Abstract    

    Abstract available

  91. GARFIELD BE, Crosby A, Shao D, Yang P, et al
    Growth/differentiation factor 15 causes TGFbeta-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertension.
    Thorax. 2019;74:164-176.
    Abstract    

    Abstract available

  92. SONG S, Lee SE, Oh SK, Jeon SA, et al
    Demographics, treatment trends, and survival rate in incident pulmonary artery hypertension in Korea: A nationwide study based on the health insurance review and assessment service database.
    PLoS One. 2018;13:e0209148.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;